A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]

Trial Profile

A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Sep 2016

At a glance

  • Drugs AUT 00063 (Primary)
  • Indications Hearing loss
  • Focus Therapeutic Use
  • Acronyms CLARITY-1
  • Sponsors Autifony Therapeutics
  • Most Recent Events

    • 14 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 18 Apr 2016 Status changed from recruiting to active, no longer recruiting.
    • 24 Nov 2015 Planned End Date changed from 1 Mar 2016 to 1 Jul 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top